| Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial S Saussele, J Richter, J Guilhot, FX Gruber, H Hjorth-Hansen, A Almeida, ... The Lancet Oncology 19 (6), 747-757, 2018 | 600 | 2018 |
| Bone involvement in sickle cell disease A Almeida, I Roberts British journal of haematology 129 (4), 482-490, 2005 | 504 | 2005 |
| Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency AM Almeida, Y Murakami, DM Layton, P Hillmen, GS Sellick, Y Maeda, ... Nature medicine 12 (7), 846-851, 2006 | 264 | 2006 |
| Randomized phase III study of lenalidomide versus placebo in RBC transfusion-dependent patients with lower-risk non-del (5q) myelodysplastic syndromes and ineligible for or … V Santini, A Almeida, A Giagounidis, S Gröpper, A Jonasova, N Vey, ... Journal of Clinical Oncology 34 (25), 2988-2996, 2016 | 254 | 2016 |
| Acute myeloid leukemia in the older adults AM Almeida, F Ramos Leukemia research reports 6, 1-7, 2016 | 196 | 2016 |
| The use of recombinant factor VIIa in children with inherited platelet function disorders AM Almeida, K Khair, I Hann, RI Liesner British Journal of Haematology 121 (3), 477-481, 2003 | 190 | 2003 |
| Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia—from molecular mechanisms to clinical relevance R Alves, AC Gonçalves, S Rutella, AM Almeida, J De Las Rivas, ... Cancers 13 (19), 4820, 2021 | 124 | 2021 |
| Targeted therapy for inherited GPI deficiency AM Almeida, Y Murakami, A Baker, Y Maeda, IAG Roberts, T Kinoshita, ... New England Journal of Medicine 356 (16), 1641-1647, 2007 | 112 | 2007 |
| Validation of the revised international prognostic scoring system (IPSS‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European … L de Swart, A Smith, TW Johnston, D Haase, J Droste, P Fenaux, ... British journal of haematology 170 (3), 372-383, 2015 | 110 | 2015 |
| Neonatal screening for haemoglobinopathies: the results of a 10‐year programme in an English Health Region AM Almeida, JS Henthorn, SC Davies British journal of haematology 112 (1), 32-35, 2001 | 88 | 2001 |
| Cessation of tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients with deep molecular response: results of the Euro-Ski trial F Mahon, J Richter, J Guilhot, H Hjorth-Hansen, A Almeida, ... Blood 128 (22), 787, 2016 | 87 | 2016 |
| EURO-SKI investigators. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective … S Saussele, J Richter, J Guilhot, FX Gruber, H Hjorth-Hansen, A Almeida, ... Lancet Oncol 19 (6), 747-757, 2018 | 80 | 2018 |
| Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms G Silva, BA Cardoso, H Belo, AM Almeida PloS one 8 (1), e53766, 2013 | 72 | 2013 |
| Phase III, randomized, placebo-controlled trial of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes G Garcia-Manero, V Santini, A Almeida, U Platzbecker, A Jonasova, ... Journal of Clinical Oncology 39 (13), 1426-1436, 2021 | 71 | 2021 |
| Emerging zoonoses: eco-epidemiology, involved mechanisms, and public health implications R Bueno-Marí, APG Almeida, JC Navarro Frontiers in public health 3, 157, 2015 | 70 | 2015 |
| Interim analysis of a pan European stop tyrosine kinase inhibitor trial in chronic myeloid leukemia: the EURO-SKI study FX Mahon, J Richter, J Guilhot, MC Muller, C Dietz, K Porkka, ... Blood 124 (21), 151, 2014 | 69 | 2014 |
| Proceedings of the 3rd IPLeiria’s International Health Congress: Leiria, Portugal. 6-7 May 2016 CC Tomás, E Oliveira, D Sousa, M Uba-Chupel, G Furtado, C Rocha, ... BMC Health Services Research 16, 111-242, 2016 | 64* | 2016 |
| Human bronchial epithelial cells malignantly transformed by hexavalent chromium exhibit an aneuploid phenotype but no microsatellite instability CFD Rodrigues, AM Urbano, E Matoso, I Carreira, A Almeida, P Santos, ... Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 670 (1 …, 2009 | 61 | 2009 |
| Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes L de Swart, S Crouch, M Hoeks, A Smith, S Langemeijer, P Fenaux, ... Haematologica 105 (3), 632, 2019 | 59 | 2019 |
| Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: a case series and literature review M Thorpe, A Montalvão, F Pierdomenico, F Moita, A Almeida Leukemia research 36 (8), 1071-1073, 2012 | 59 | 2012 |
